+971.7%
MRNA vs ECL
+105.5%
+866.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | ECL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -1.1% | +2.4% | +1.7% |
| 7D | -13.8% | -2.3% | -11.5% | -13.0% |
| 30D | -17.7% | +3.2% | -20.8% | -18.6% |
| 3M | +14.3% | +4.4% | +9.9% | +12.7% |
| 6M | +336.0% | +21.6% | +314.3% | +309.3% |
| YTD | +575.9% | +14.2% | +561.8% | +549.4% |
| 1Y | +724.4% | +14.9% | +709.4% | +690.4% |
| 3Y | +160.8% | +66.3% | +94.4% | +123.3% |
| 5Y | -24.4% | +33.9% | -58.3% | -35.9% |
| All | +971.7% | +105.5% | +866.1% | +526.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ECL.
Daily Out/Under-Performance
Portfolio return minus ECL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ECL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded ECL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling